SCHEMBL7791977

SCHEMBL7791977

COc1cc(OC(C)C)c(Cl)cc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.49
NPSR1 Q6W5P4 1/20 0.49
ALDH1A1 P00352 5/20 0.46
HPGD P15428 2/20 0.46
LCK P06239 1/20 0.45
FYN P06241 1/20 0.45
MRGPRX4 Q96LA9 1/20 0.44
HTT P42858 2/20 0.43
RORC P51449 1/20 0.43
GAA P10253 1/20 0.43
KMO O15229 3/20 0.42
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
KCNH2 Q12809 1/20 0.40
CYP3A4 P08684 1/20 0.39
TTR P02766 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3617721 0.86 ALDH1A1 (0.55) KDM4ENPSR1ALDH1A1HPGDLCK
SCHEMBL18312021 0.84 LCK (0.56) KDM4ENPSR1ALDH1A1HPGDLCK
SCHEMBL7015758 0.82 KDM4E (0.50) KDM4ENPSR1ALDH1A1HPGDLCK
SCHEMBL3387534 0.81 ALDH1A1 (0.56) KDM4ENPSR1ALDH1A1HPGDLCK
SCHEMBL2617486 0.81 ALDH1A1 (0.48) KDM4EALDH1A1HPGDRORCGAA
SCHEMBL6743024 0.79 LCK (0.58) KDM4ENPSR1ALDH1A1HPGDLCK
SCHEMBL11310945 0.79 LCK (0.58) KDM4ENPSR1ALDH1A1HPGDLCK
SCHEMBL10691459 0.79 LCK (0.54) KDM4ENPSR1ALDH1A1HPGDLCK
SCHEMBL8183793 0.79 P2RX3 (0.49) KDM4ENPSR1ALDH1A1HPGDLCK
SCHEMBL18309180 0.79 ALDH1A1 (0.55) KDM4ENPSR1ALDH1A1HPGDLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010025045-A1 Substituted isoquinoline derivatives and their use as anticonvulsants SMITHKLINE BEECHAM P.L.C. 2001-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010025045-A1 Substituted isoquinoline derivatives and their use as anticonvulsants INA, GRIN2C, GRIN2A KDM4E 910/4885NPSR1 532/4885ALDH1A1 494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.